Orphan Therapeutics, LLC - Specialty Pharmaceuticals for Patients in Need Orphan Therapeutics, LLC is a privately held, virtual drug development company. It and was founded in mid 2003 by Peter Teuber, Ph.D. in New Jersey with the initial purpose to develop and seek FDA approval for its first product, intravenous terlipressin, for the treatment of hepatorenal
syndrome (HRS) type 1 in the US. Orphantherapeutics.com~Site InfoWhoisTrace RouteRBL Check